A Phase 3 Comparative Study of TAP-144-SR(6M) in Postoperative and Hormone Therapy-naïve Patients With Premenopausal Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Premenopausal Breast Cancer
Interventions: DRUG: TAP-144-SR(6M)|DRUG: TAP-144-SR(3M)
Sponsor: Takeda